Is Mirtazapine Appropriate for the Elderly?

A recent study calls into question the safety of mirtazapine in the elderly, an antidepressant often recommended in the elderly for treatment of senile cachexia due to the medication’s appetite stimulation properties. This episode reviews the SYMBAD trial with guest Sarah Grady, PharmD.Guest:Sarah Grady, PharmDDrake UniversityRedeem your CPE or CME credit here!Pharmacist membersCMENeed a membership?Join for CPE CreditJoin for CME Credit References and resources: Banerjee S, High J, Stirling S, et al. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1. PMID: 34688369; PMCID: PMC8546216.Continuing Education Information:Learning Objectives: Describe the results of the SYMBAD study and its implications in the care of geriatric patientsDiscuss the adverse effects found in the SYMBAD study Dr. Sarah Grady reports no actual or potential conflicts of interest associated with this episode.0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-401-H01-PInitial release date: 12/20/21Expiration date: 12/20/22Additional CPE & CME details can be found here (www.ceimpact.com/podcast)Follow CEimpact on Social Media:LinkedInInstagram